Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4199-4206

  Rigby, W F C ^a,b,c   Waugh, M G ^a   Hamilton, B J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 39; PROTEIN; PROTEIN P25; PROTEIN P50; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; HUMAN; HUMAN CELL; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY MECHANISM; RNA METABOLISM; T LYMPHOCYTE;

3' UNTRANSLATED REGIONS; ANTIGENS, CD40; BINDING SITES; CD40 LIGAND; CELLS, CULTURED; HUMANS; IONOMYCIN; IONOPHORES; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MOLECULAR WEIGHT; PHYTOHEMAGGLUTININS; POLYRIBOSOMES; RNA, MESSENGER; RNA-BINDING PROTEINS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0032825226     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hollenbaugh, D., H. D. Ochs, R. J. Noelle, J. A. Ledbetter, and A. Aruffo. 1994. The role of CD40 and its ligand in the regulation of the immune response. Immunol. Rev. 138:23.
2. Foy, T. M., A. Aruffo, J. Bajorath, J. E. Buhlmann, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
3. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415.
4. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu Rev. Immunol. 16:111.
5. + T cells. J. Immunol. 151:2497.
6. Lane, P. A. Traunecker, S. Hubele, S. Inui, A. Lanzavecchia, and D. Gray. 1992. Activated human T cells express a ligand for the human B cell-associated antigen CD40, which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573.
7. Nusslein, H. G., K. H. Frosch, W. Woith, P. Lane, J. R. Kalden, and B. Manger. 1996. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur. J. Immunol. 26:846.
8. Martin, P. J., J. A. Ledbetter, Y. Morishita, C. H. June, P. J. Beatty, and J. A. Hansen. 1986. A 44 kDa cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J. Immunol. 136:3282.
9. Thompson, C. B., T Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. J. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
10. Roy, M., A. Aruffo, J. A. Ledbetter, P. Linsley, M. Kehry, and R. Noelle. 1994. Studies an the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596.
11. deBoer, M., A. Kasran, J. Kwekkeboom, H. Walter, P. Vandenberghe, and J. L. Ceuppens. 1993. Ligation of B7 with CD28/CTLA-4 results in CD40 ligand expression, interleukin 4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120.
12. Fuleihan, R., N. Ramesh, A. Horner, D. Ahern, P. J. Belshaw, D. G. Alberg, I. Stamenkovic, W. Harmon, and R. S. Geha. 1994. Cyclosporin A inhibits CD40 ligand expression in human T lymphocytes. J. Clin. Invest. 93:1315.
13. Schubert, L. A., G. King, R. Q. Cron, D. B. Lewis, A. Aruffo, and D. Hollenbaugh. 1995. The human gp39 promoter: two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J. Biol. Chem. 15:29264.
14. + memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor. J. Exp. Med. 181:1293.
15. MacDonald, K. P., Y. Nishioka, P. E. Lipsky, and R. Thomas. 1997. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J. Clin. Invest. 100: 2404.
16. Yellin, M. J., K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee, J. Sinning, E. A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface-B cell activating molecule/CD40-L: potential role in regulating helper effector function. J. Immunol. 152:598.
17. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-α primary mediator of the host response. Annu. Rev. Immunol. 7:625.
18. Hamilton, B. J., E. Nagy, J. S. Malter, B. A. Arrick, and W. F. C. Rigby. 1993. Association of hnRNP Al and C proteins with reiterated AUUUA-sequences. J. Biol. Chem. 268:8881.
19. Jain, R. G., L. G. Andrews, K. M. McGowan, P. H. Pekala, and J. D. Keene. 1997. Ectopic expression of He1-N1, an RNA binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol. Cell. Biol. 17:954.
20. Ma, W. J., S. Chung. and H. Furneaux. 1997. The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA. Nucleic Acids Res. 25:3564.
21. Fan, X. C., and J. A. Steitz. 1998. Overexpression of HuR, a nucleocytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162: 156.
23. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.
24. Henics, T., A. Sanfridson, B. J. Hamilton, and W. F. C. Rigby. 1994. Enhanced stability of interleukin 2 mRNA in MLA-144 cells: possible role of AU-rich sequence binding proteins (AUBP). J. Biol. Chem. 269:5377.
25. Dignam, J. D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription by RNA polymerase II in soluble extract from mammalians nuclei. Nucleic Acids Res. 11:1475.
26. Brewer, G., and J. Ross. 1990. Messenger RNA turnover in cell-free extracts. Methods Enzymol. 181:202.
27. Foy, T. M., M. McIlraith, S. R. Masters, J. J. Dunn, A. A. Rossini, L. D. Shultz, R. A. Hesselton, E. J. Wagar, P. E. Lipsky, R. J. Noelle, and D. L. Greiner. 1998. Blockade of CD40-CD154 interferes with human T cell engraftment in SCID mice. Cell Transplant. 7:25.
28. Lindslen, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
29. Nagy, E., J. E. Buhlmann,T. Henics T, M. Waugh, and W. F. C. Rigby. 1994. Selective modulation of IFN-γ mRNA stability by IL-12/NKSF. Cell. Immunol. 159:140.
30. Chen, C.-Y.A., T.-M. Chen, and A.-B. Shyu. 1994. Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA destabilizing function. Mol. Cell. Biol 14:416.
31. Wodnar-Filipowicz, A., and C. Moroni. 1990. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc. Natl. Acad. Sci. USA 87:771.
32. Suarez, A., L. Mozo, A. Gayo, J. Zamorano, and C. Gutierrez. 1997. Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand: involvement of transcriptional and posttranscriptional mechanisms. Eur. J. Immunol. 27:2822.
33. Ford, G. S., B. Barnhart, S. Shone, and L. R. Covey. 1999. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J. Immunol. 162:4037.
34. Klausner, R. D., and J. B. Harford. 1989. Cis-trans models for posttranscriptional gene regulation. Science 246:870.
35. Curatola, A. M, M. S. Nadal, and R. J. Schneider. 1995. Rapid degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5′ to the ARE. Mol. Cell. Biol. 15:6331.
36. Shaw, G., and R. Karnen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:659.
37. Ross, J. 1988. Messenger RNA turnover in eukaryotic cells. Mol. Biol. Med. 5:1.
38. Koshy, M., D. Berger, and M. K. Crow. 1996. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98:826.